Pablo A. Olivera

1.9k total citations · 2 hit papers
44 papers, 1.3k citations indexed

About

Pablo A. Olivera is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Pablo A. Olivera has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 17 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Pablo A. Olivera's work include Inflammatory Bowel Disease (33 papers), Microscopic Colitis (16 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Pablo A. Olivera is often cited by papers focused on Inflammatory Bowel Disease (33 papers), Microscopic Colitis (16 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Pablo A. Olivera collaborates with scholars based in Argentina, France and Italy. Pablo A. Olivera's co-authors include Laurent Peyrin‐Biroulet, Silvio Danese, Juan S. Lasa, Juan S. Lasa, Stefanos Bonovas, Nicolas Jay, Gioacchino Natoli, Paulo Gustavo Kotze, Alain Attar and Laura Martelli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Pablo A. Olivera

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis

2021 235 citations Juan S. Lasa, Pablo A. Olivera et al. The Lancet. Gastroenterology & hepatology profile →
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

2020 226 citations Pablo A. Olivera, Juan S. Lasa et al. Gastroenterology profile →

Peers

Pablo A. Olivera

GENET

EPIDE

SURGE

IMMUN

RHEUM

Deborah Woodworth United States

Eric Vasiliauskas United States

Ian C. Lawrance Australia

Yoichi Kakuta Japan

Paul J. Healey United States

Lieven Pouillon Belgium

Zhirong Zeng China

Gian Lodovico Rapaccini Italy

Pál Miheller Hungary

Paula Lago Portugal

Deborah Woodworth United States

Pablo A. Olivera

1.1k ×1.3

GENET

794 ×1.4

EPIDE

339 ×1.2

SURGE

313 ×1.2

IMMUN

244 ×1.3

RHEUM

Citations per year, relative to Pablo A. Olivera Pablo A. Olivera (= 1×) peers Deborah Woodworth

Countries citing papers authored by Pablo A. Olivera

Since Specialization

Citations

This map shows the geographic impact of Pablo A. Olivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo A. Olivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo A. Olivera more than expected).

Fields of papers citing papers by Pablo A. Olivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo A. Olivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo A. Olivera. The network helps show where Pablo A. Olivera may publish in the future.

Co-authorship network of co-authors of Pablo A. Olivera

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo A. Olivera. A scholar is included among the top collaborators of Pablo A. Olivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo A. Olivera. Pablo A. Olivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allocca, Mariangela, Federica Furfaro, Alessandra Zilli, et al.. (2025). Biobetters and biosimilars in inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology. 77. 101992–101992. 3 indexed citations

Olivera, Pablo A., Cristian Hernández-Rocha, Williams Turpin, et al.. (2025). Isolated Anastomotic Ulcers Are Associated with a Higher Long-Term Risk for Postoperative Recurrence and a Differential Mucosa-Associated Microbiome Composition in Patients with Crohn’s Disease Following Ileocolic Resection. Inflammatory Bowel Diseases. 31(12). 3247–3255. 1 indexed citations

Olivera, Pablo A., Ji-Eun Kim, Geoffrey C. Nguyen, et al.. (2025). P1101 Real-world effectiveness and safety of Risankizumab in Crohn’s Disease. Journal of Crohn s and Colitis. 19(Supplement_1). i2023–i2024. 1 indexed citations

Olivera, Pablo A., et al.. (2024). Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study. Gastroenterología y Hepatología. 48(8). 502287–502287.

Balderramo, Domingo, Abel Botelho Quaresma, Pablo A. Olivera, et al.. (2024). Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America. The Lancet. Gastroenterology & hepatology. 9(3). 263–272. 18 indexed citations

Qaiyum, Zoya, Michael Tang, Pablo A. Olivera, & Robert D. Inman. (2023). Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation. The Journal of Rheumatology. 50(8). 1090–1092. 2 indexed citations

Olivera, Pablo A. & Mark S. Silverberg. (2023). Biomarkers That Predict Crohn’s Disease Outcomes. Journal of the Canadian Association of Gastroenterology. 7(1). 59–67. 3 indexed citations

Olivera, Pablo A., Juan S. Lasa, Giovanni Peretto, et al.. (2023). Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs. Alimentary Pharmacology & Therapeutics. 57(11). 1231–1248. 26 indexed citations

Queiroz, Natália Sousa Freitas, et al.. (2023). IBD barriers across the continents: a continent-specific analysis: Latin America. Therapeutic Advances in Gastroenterology. 16. 1108350929–1108350929. 6 indexed citations

10.

Olivera, Pablo A., Juan S. Lasa, Vipul Jairath, et al.. (2022). Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Crohn s and Colitis. 17(2). 199–210. 5 indexed citations

11.

Olivera, Pablo A., et al.. (2022). Significance of HLA-B[*]51 allele expression in Crohn's disease: a case-control study. Clinical and Experimental Rheumatology. 41(10). 2044–2047. 1 indexed citations

12.

Lasa, Juan S., Pablo A. Olivera, Stefanos Bonovas, Silvio Danese, & Laurent Peyrin‐Biroulet. (2021). Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis. Drug Safety. 44(6). 645–660. 24 indexed citations

13.

D’Amico, Ferdinando, Virginia Solitano, Daniel Aletaha, et al.. (2021). Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus. Autoimmunity Reviews. 20(7). 102849–102849. 21 indexed citations

14.

Lasa, Juan S., et al.. (2020). Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study. Gastroenterology Research and Practice. 2020. 1–9. 16 indexed citations

15.

Olivera, Pablo A., Juan S. Lasa, Stefanos Bonovas, Silvio Danese, & Laurent Peyrin‐Biroulet. (2020). Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis. Gastroenterology. 158(6). 1554–1573.e12. 226 indexed citations breakdown →

16.

Olivera, Pablo A., et al.. (2020). Effect of successive endoscopic procedures in polyp and adenoma detection rates: Too early is not always too good. Indian Journal of Gastroenterology. 39(5). 450–456.

17.

Olivera, Pablo A., Silvio Danese, Lieven Pouillon, Stefanos Bonovas, & Laurent Peyrin‐Biroulet. (2018). Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence. Digestive and Liver Disease. 51(3). 327–334. 17 indexed citations

18.

Olivera, Pablo A., Antonino Spinelli, Corinne Gower‐Rousseau, Silvio Danese, & Laurent Peyrin‐Biroulet. (2017). Surgical rates in the era of biological therapy. Current Opinion in Gastroenterology. 33(4). 246–253. 54 indexed citations

19.

Clerc‐Urmès, Isabelle, Adeline Germain, Laurent Bresler, et al.. (2017). Value of cross-sectional imaging in assessing active Crohn’s disease before stoma reversal. Digestive and Liver Disease. 49(8). 864–871. 3 indexed citations

20.

Olivera, Pablo A., et al.. (2017). Treatment Persistence for Infliximab Versus Adalimumab in Crohnʼs Disease. Inflammatory Bowel Diseases. 23(6). 976–985. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact